Â
Â
Vaccines can be cash cows for pharmaceutical companies like Pfizer (NYSE: PFEÂ Â ) , GlaxoSmithKline (NYSE: GSKÂ Â ) , Sanofi (NYSE: SNYÂ Â ) , and Novartis (NYSE: NVSÂ Â ) . If a company can get on the preferred list with government agencies, sales will come pouring in.
But then what? There are only so many short people needing vaccinations. Except for hoping for a baby boom, there aren't many options for increasing sales.
Â
Â
Â
Â
Â
We'll know soon enough if Pfizer can make money at both ends of the life cycle; the FDA is currently reviewing the marketing application.
Â
Â
of course it can - and it will. This infuriates me. Everytime I read an article like this the lyrics of that song "It's all about the money" by Meja comes into my head!!





